| Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. | |
| | |
MedLine Citation:
|
PMID: 18591435 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Ischemic preconditioning provides strong cardioprotection from ischemia, but its molecular mechanisms remain unknown. Convincing evidence confirms a central role of hypoxia-inducible factor (HIF)-1 in mammalian oxygen homeostasis. Thus, we pursued HIF-1 as a central component of cardioprotection by ischemic preconditioning. METHODS AND RESULTS: Murine studies of in situ preconditioning revealed a robust activation of cardiac HIF-1. Moreover, in vivo small interfering RNA repression of cardiac HIF-1 resulted in abolished cardioprotection by ischemic preconditioning. In contrast, pretreatment with the HIF activator dimethyloxalylglycine was associated with cardioprotection similar to that of ischemic preconditioning itself. Finally, selective small interfering RNA repression of prolylhydroxylase 2 resulted in significant activation of HIF-1 alpha and attenuated myocardial infarct sizes (0.44+/-0.09-fold). As an end point of HIF-dependent cardioprotection, we defined the role of A2B adenosine receptor (A2BAR) signaling. Although the cardiac A2BAR was induced with HIF activation, HIF-dependent cardioprotection was abolished in A2BAR-/- mice. CONCLUSION: Taken together, these studies provide evidence for a critical role of HIF-1 in ischemic preconditioning via enhancing purinergic signaling pathways. |
| | |
Authors:
|
Tobias Eckle; David Köhler; Rainer Lehmann; Karim El Kasmi; Holger K Eltzschig |
Related Documents
:
|
16293265 - Ceramide-induced preconditioning involves reactive oxygen species. 7954615 - Ischaemic preconditioning by partial occlusion without intermittent reperfusion. 11123255 - Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on bo... 16007235 - Ktx 0101: a potential metabolic approach to cytoprotection in major surgery and neurolo... 8879955 - Calcium-channel blockers in ischemic heart disease. 17389455 - Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myo... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Circulation Volume: 118 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-10 Completed Date: 2008-07-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 166-75 Citation Subset: AIM; IM |
Affiliation:
|
Department of Anesthesiology and Intensive Care Medicine, University Hospital, Tübingen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acids, Dicarboxylic
/
pharmacology Animals Hypoxia-Inducible Factor 1, alpha Subunit / agonists, physiology* Ischemic Preconditioning* Mice Mice, Knockout Myocardial Infarction / drug therapy Procollagen-Proline Dioxygenase / drug effects RNA, Small Interfering / pharmacology Receptor, Adenosine A2B / deficiency, physiology* Signal Transduction |
| Chemical | |
Reg. No./Substance:
|
0/Amino Acids, Dicarboxylic; 0/Hypoxia-Inducible Factor 1, alpha Subunit; 0/RNA, Small Interfering; 0/Receptor, Adenosine A2B; 5262-39-5/oxalylglycine; EC 1.14.11.2/Procollagen-Proline Dioxygenase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary ...
Next Document: Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.